Physician profile
Karim Nooruddin
NPI 1386647253
$788.17
in general payments reported to CMS, 2019-2025
13 companies · $98.23 in 2025
The $98.23 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.39 · 2020: $126 · 2021: $77.37 · 2022: $196 · 2023: $99.54 · 2024: $97.65 · 2025: $98.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222 · Education: $73.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $222.21 |
| Education | $73.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $224.75 | 2022-2025 | |
| Amgen INC. | $131.70 | 2020-2025 | Tavneos |
| Fresenius USA Marketing, INC. | $87.94 | 2019-2022 | |
| Horizon Therapeutics Plc | $78.49 | 2021-2022 | |
| Vifor Pharma, INC. | $76.13 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $33.09 | 2020-2021 | |
| Glaxosmithkline, LLC. | $32.31 | 2022 | |
| Apellis Pharmaceuticals, INC. | $30.29 | 2023 | Empaveli |
| Aurinia Pharma U.S., INC. | $29.38 | 2023-2024 | Lupkynis |
| Medtronic, INC. | $27.92 | 2025 | Symplicity G3 |
| Novartis Pharmaceuticals Corporation | $24.24 | 2025 | |
| Opko Pharmaceuticals, LLC | $8.85 | 2020 | |
| Travere Therapeutics, INC. | $3.08 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karim Nooruddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.